stock.name

Gain Therapeutics Inc

GANX

Market Cap$90.82M
Close$

Compare Gain Therapeutics

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Gain Therapeutics IncGain Therapeutics Inc-4.10%-303%-0.1
marketMarket Avg49.61.28%30%6.11.1
HealthcareHealthcare Avg32.71.25%19%7.40.9

Share Statistics

Market cap$90.82 Million
Enterprise Value$79.63 Million
Dividend Yield$0.0 (0.0%)
Earnings per Share$-1.82
Beta1.06
Outstanding Shares20,455,518
Avg 30 Day Volume253,860

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-4.09
PEG-116.42
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue1443.07
Enterprise Value to EBIT-3.55
Enterprise Value to Net Income-4
Total Debt to Enterprise0.01
Debt to Equity0.14

Revenue Sources

No data

ESG Score

No data

About Gain Therapeutics Inc

16 employees

Gain Therapeutics, Inc. is redefining drug discovery with its See-Tx™ target identification platform. By identifying and optimizing allosteric binding sites that have never before been targeted, Gain is unlocking new treatment options fo...